News and Announcements
2OPAL announces partnership with Choco Up, Asia’s leading revenue-based financing investor
- Published October 07, 2022 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Opal is one of the first licensed neo banks in Asia offering the full suite of financial solutions focused on international commerce and trade – multi-currency wallets, payments, financing & growth capital, escrow and collections from across 180 countries. Users can access a marketplace of solution providers through a single dashboard.
Opal, a neo-bank licensed by the Monetary Authority of Singapore (MAS), is announcing its partnership with a financing partner, Choco Up, the leading revenue-based financing investor in Asia.
Opal, a Major Payment Institution (MPI) licensed by the Monetary Authority of Singapore (MAS), is announcing its partnership with a financing partner, Choco Up, the leading revenue-based financing investor in Asia. Together, they will offer a range of financing solutions to e-commerce and digital companies, the most unique of which, is revenue-based financing (“RBF”). RBF is unique in the region as applicants only need to repay a percentage of their revenue. The solution matches the applicant’s revenue numbers as it can grow and ebb to reduce pressure on their cash flow. There is also one flat fee making the cost of financing truly transparent. It takes 30 seconds to register for an account and get a preliminary offer in 5 minutes.
As long as companies use Opal to receive payments, giving visibility into their receivables, the qualification criteria for the RBF is easier and the fee is less. Users get multi-currency accounts, financing, and payments on a single Opal account.
Connect with the company and learn more about OPAL by accessing their deal room here.
Company Updates
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Dying for a Cure: Why Astraea is Stress-Testing the Future of Space Medicine
Astraea Technologies is solving a critical “blind spot” in the $1.5T space economy. Co-founders Brooke Mills and Gordon Carroll discuss their $5M seed raise, the HIRO-LAB platform, and their upcoming 2028 mission to the Moon to validate life-saving medicine in extreme environments.
Beyond the Drip: Elemental IV’s Infrastructure Play for a Fragile Supply Chain
In the high-stakes world of life sciences, we often hunt for the next “miracle molecule” or gene-editing breakthrough. But Storme Paes, Founder and Commercial Director of Elemental IV, found her mission in something far more fundamental, yet dangerously overlooked: a simple bag of saltwater. The “Meeting Room” Revelation The genesis of Elemental IV didn’t occur […]
Backed By Leading Investment Groups and Family Offices
